Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Daily
25m
Pfizer RSV Vaccine Abrysvo gets USFDA ok for high-risk adults aged 18-59
The approval for the vaccine, Abrysvo, in adults aged 18 to 59 was based on the results from a late stage trial in which two doses of the vaccine were teste ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Linked to E. coli outbreak
Arrested in trafficking case
Arlington visit records order
To appear on Rogan podcast
To close 150 locations
Lake Erie toxic algae study
MO court upholds release
2 US troops injured in raid
Veteran film producer dies
Trespassing charge upheld
Giant ‘ghost’ fish spotted
Six indicted for fraud in Ohio
DOJ alleges racial bias
GA election rules appeal
FDA approves RSV vaccine
Brain stimulation study
FAA finalizes safety rules
SK mulls arms for Ukraine
Target to cut prices
Raises US growth forecast
Hospitals' IV fluid shortage
Same-day pharmacy delivery
Ordered to hand over assets
Probing leak of US intel
2025 Medicare changes
To headline 2 Harris rallies
Infant mortality increased
US semiconductor tax credit
Right whale population rises
Reveals 2025 tax brackets
Related topics
RSV vaccine
Food and Drug Administration
Feedback